期刊文献+

活菌疫苗载体的研究与应用 被引量:1

The Application of Bacterial Carriers in Vaccine Study
下载PDF
导出
摘要 目前在疫苗研究中,要求新型疫苗不仅能够激发高效持久的免疫应答,而且应易于接种、生产费用低。减毒或无毒的活微生物作为疫苗载体能够激起持久的系统和黏膜免疫反应,批量制备成本较低,且具有良好的安全性,近年来已成为疫苗研究领域的热点。本文综述了几种活菌疫苗载体,包括沙门氏菌、卡介苗、耶尔森菌等的研究状况及其在疫苗载体方面的应用。 There is an increasing need for novel vaccines able to stimulate efficient and long-lasting responses, which have also low production costs. Live recombinant bacteria can meet the above needs to induce the both mucosal and systemic immune responses against heterologous antigens. Recent years, using live bacteria as vaccine vectors are becoming hotspot in the field of vaccine research and development. In this review, the most extensively studied bacterial carriers including Salmonella spp, BCG, Yersinia enterocolitica etc and their respective usage in vaccine were discussed.
出处 《生物技术通讯》 CAS 2005年第4期414-416,共3页 Letters in Biotechnology
关键词 黏膜免疫 疫苗 活菌疫苗载体 mucosal immunity vaccines live bacteria vaccine vectors
  • 相关文献

参考文献26

  • 1石辛甫.减毒活细菌在肿瘤治疗中的作用[J].国外医学(肿瘤学分册),2003,30(1):64-67. 被引量:5
  • 2Chen Hongming. Recent advances in mucosal vaccine development [J]. J Controlled Release, 2000,67:117. 被引量:1
  • 3Medina E, Guzman CA. Use of bacterial vaccine vectors for antigen delivery: potential and limitations[J]. Vaccine, 2001,19:1573. 被引量:1
  • 4Drabner B, Guzman CA. Elicitation of predictable immune responses by using live bacterial vectors [J]. Biomolecular Engineering,2001,17:75. 被引量:1
  • 5王剑虹,孙述学.疫苗投递的新策略[J].微生物学免疫学进展,2004,32(2):62-67. 被引量:4
  • 6Lande RG, Guzman C, Weiss S, et al. Gram-positive bacteria as vaccine vehicles for mucosal immunization,intelligence unit series[J].Biomedical Publishers, 1997:145. 被引量:1
  • 7Actor JK, Shirai M, Kullberg MC, et al. Helminth infection results in decreased virus-specific CD8+ cytofine responses as well as delayed virus clearance[J]. Proc Natl Acad Sci USA, 1993,90(3):948. 被引量:1
  • 8Melief CJM. Tumner eradication by adoptive transfer of cytotoxic Tlymphocytes[J]. Adv Cancer Res, 1992,58:143. 被引量:1
  • 9Walker RI. New strategies for using mucosal vaccination to achieve more effective immunization[J]. Vaccine, 1994,12(50):387. 被引量:1
  • 10Bumann D, Hueck C, Aebischer T, et al. Recombinant live Salmonella spp for human vaccination against heterologous pathogens[J]. Immunol Medical Microbiol, 2000,27:357. 被引量:1

二级参考文献90

  • 1利用卡介苗系统生产糖尿病疫苗[J].国外医学,1999,22(6):279-279. 被引量:1
  • 2Murray A,Winter N,Lagranderia M,et al.Expression of Escherichia coli β-galactosidase in mycobacterium bovis BCG using an expression system isolated from mycobacterium paratu-berculosis which induced humoral and cellularimmune responses[J].Mol Microbiol 1992,6:3331-3342. 被引量:1
  • 3Winter N, Lagranderie M, Gangloff S, et al. Recombinant BCG strains expressing the SIV mac251 nef gene induce proliferative and CTL responses against nef synthetic peptides in mice[J]. Vaccine 1995,13:471-478. 被引量:1
  • 4Lim EM,Lagranderie M,Le Grand R,et al.Recombinant mycobacterium bovis BCG producing the N-terminal half of SIV mac251 Env antigen induces neutralizing antibodies and cytotoxic T lymphocyte responses in mice and guinea pigs[J].J Virol 1997,71:2303-2309. 被引量:1
  • 5Mederle, Bourguln, Ensergueis, et 81. Plasmidicversus insertional cloning of heterologous genes in mycobacterium bovis BCG:impact on in vivo antigen persistence and Immune Responses[J].Infect Immun 2002,70:303-314. 被引量:1
  • 6Abomoelak B,Huygen K,Kremer L,et al.Humoral and cellular immune responses in mice immunized with recombinant mycobacterium bovis bacillus calmette-guerin producing a peryussis toxin-tetanus toxin hybrid protein[J].Infect Immun 1999,67:5100-5105. 被引量:1
  • 7Nascimento IP,Dias WO,Mazzantini RP,et al.Recombinant mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live bordetella pertussis in mice[J].Infect Immun 2000,68:4877-4883. 被引量:1
  • 8Naoya O,Matsuoka H, Hiroko N, et al. Protective responses against experimental mycobacterium lepra infection in mice induced by recombinant bacillus Calmette-Guerin over-producing three putative protective antigen candidates[J]. Vaccine 2001,19:1906-1910. 被引量:1
  • 9Flaeseleer F,Pollet J F, Haumont M,et al. Stable integration and expression of plasmodium falciparum circumsporozoite protein coding sequence in mycobacteria [J]. Mol Biol Parasit 1993,57:117-126. 被引量:1
  • 10Baulard A, Kremer L, Supply P, et al. A new series of mycobacterial expression vectors for the development of live recombinant vaccines[J]. Gene 1996,176:149-154. 被引量:1

共引文献15

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部